Cargando…

A 4K score/MRI‐based nomogram for predicting prostate cancer, clinically significant prostate cancer, and unfavorable prostate cancer

BACKGROUND: The detection of prostate cancer requires histological confirmation in biopsy core. Currently, number of unnecessary prostate biopsies are being performed in the United States. This is due to the absence of appropriate biopsy decision‐making protocol. AIM: To develop and validate a 4K sc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wagaskar, Vinayak G., Sobotka, Stanislaw, Ratnani, Parita, Young, James, Lantz, Anna, Parekh, Sneha, Falagario, Ugo Giovanni, Li, Li, Lewis, Sara, Haines, Kenneth, Punnen, Sanoj, Wiklund, Peter, Tewari, Ash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388161/ https://www.ncbi.nlm.nih.gov/pubmed/33661541 http://dx.doi.org/10.1002/cnr2.1357

Ejemplares similares

Clinical Utility of Negative Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer and Clinically Significant Prostate Cancer
por: Wagaskar, Vinayak G., et al.
Publicado: (2021)

A SelectMDx/magnetic resonance imaging‐based nomogram to diagnose prostate cancer
por: Wagaskar, Vinayak G., et al.
Publicado: (2022)

Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists
por: Dovey, Zachary, et al.
Publicado: (2020)

Increased Hospitalization and Mortality from COVID-19 in Prostate Cancer Patients
por: Chakravarty, Dimple, et al.
Publicado: (2021)

Unified model involving genomics, magnetic resonance imaging and prostate‐specific antigen density outperforms individual co‐variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancer
por: Beksac, Alp Tuna, et al.
Publicado: (2021)

The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator
por: Parekh, Sneha, et al.
Publicado: (2022)

Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer
por: Chakravarty, Dimple, et al.
Publicado: (2022)

Association between Expression of Connective Tissue Genes and Prostate Cancer Growth and Progression
por: Treacy, Patrick-Julien, et al.
Publicado: (2023)

‘Stealth’ Prostate Tumors
por: Wagaskar, Vinayak G., et al.
Publicado: (2023)

Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
por: Chakravarty, Dimple, et al.
Publicado: (2020)

Side-specific, Microultrasound-based Nomogram for the Prediction of Extracapsular Extension in Prostate Cancer
por: Pedraza, Adriana M., et al.
Publicado: (2022)

Multiphoton Microscopy for Identifying Collagen Signatures Associated with Biochemical Recurrence in Prostate Cancer Patients
por: Pavlova, Ina P., et al.
Publicado: (2021)

Entering an era of radiogenomics in prostate cancer risk stratification
por: Soodana-Prakash, Nachiketh, et al.
Publicado: (2018)

Divorcing Diagnosis From Treatment: Contemporary Management of Low-Risk Prostate Cancer
por: Glass, Allison S., et al.
Publicado: (2013)

Impact of Meat Consumption, Preparation, and Mutagens on Aggressive Prostate Cancer
por: Punnen, Sanoj, et al.
Publicado: (2011)

Imaging for the selection and monitoring of men on active surveillance for prostate cancer
por: Velasquez, Maria C., et al.
Publicado: (2018)

Multiparametric-MRI and Targeted Biopsies in the Management of Prostate Cancer Patients on Active Surveillance
por: Sandler, Kiri, et al.
Publicado: (2015)

Development and Internal Validation of Novel Nomograms Based on Benign Prostatic Obstruction-Related Parameters to Predict the Risk of Prostate Cancer at First Prostate Biopsy
por: Cormio, Luigi, et al.
Publicado: (2018)

Optimizing patient's selection for prostate biopsy: A single institution experience with multi-parametric MRI and the 4Kscore test for the detection of aggressive prostate cancer
por: Punnen, Sanoj, et al.
Publicado: (2018)

Nationally-representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America Project
por: Cary, K. Clint, et al.
Publicado: (2015)

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
por: Stoyanova, Radka, et al.
Publicado: (2016)

Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness
por: Parra, Nestor Andres, et al.
Publicado: (2017)

Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate Cancer
por: Hougen, Helen Y., et al.
Publicado: (2023)

Luteinizing Hormone Levels Relate to the Unfavorable Pathology of Prostate Cancer
por: Choi, Se Young, et al.
Publicado: (2020)

Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms
por: Tzeng, Michael, et al.
Publicado: (2021)

Ethnic heterogeneity and prostate cancer mortality in Hispanic/Latino men: a population-based study
por: Chinea, Felix M., et al.
Publicado: (2017)

Prostate Cancer Postoperative Nomogram Scores and Obesity
por: Major, Jacqueline M., et al.
Publicado: (2011)

Comparison of the efficiency and complications of Lumenis and Wolf morcellators after holmium laser enucleation of the prostate
por: Maheshwari, Pankaj N., et al.
Publicado: (2018)

Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients?
por: Falagario, Ugo Giovanni, et al.
Publicado: (2021)

Clinical characteristics and prostate-cancer-specific mortality of competitive risk nomogram in the second primary prostate cancer
por: Xu, Chaojie, et al.
Publicado: (2023)

Integration of magnetic resonance imaging into prostate cancer nomograms
por: Brinkley, Garrett J., et al.
Publicado: (2022)

Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy
por: Falagario, Ugo Giovanni, et al.
Publicado: (2021)

Generative Adversarial Networks Can Create High Quality Artificial Prostate Cancer Magnetic Resonance Images
por: Xu, Isaac R. L., et al.
Publicado: (2023)

Impact of perioperative factors on nadir serum prostate‐specific antigen levels after holmium laser enucleation of prostate
por: Martos, Mary, et al.
Publicado: (2021)

Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients
por: Lu, Jianlei, et al.
Publicado: (2015)

Grade and stage misclassification in intermediate unfavorable‐risk prostate cancer radiotherapy candidates
por: Sorce, Gabriele, et al.
Publicado: (2022)

Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors
por: Parra, Andres N., et al.
Publicado: (2018)

Comparison of cancer detection rates by transrectal prostate biopsy for prostate cancer using two different nomograms based on patient’s age and prostate volume
por: Hori, Shunta, et al.
Publicado: (2019)

Development and external validation of a prostate health index-based nomogram for predicting prostate cancer
por: Zhu, Yao, et al.
Publicado: (2015)

MultiParametric Magnetic Resonance Imaging-Based Nomogram for Predicting Prostate Cancer and Clinically Significant Prostate Cancer in Men Undergoing Repeat Prostate Biopsy
por: Huang, Cong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tm5cben0j7pj2cl8kqkdt8t33v